JP2018524973A5 - - Google Patents

Download PDF

Info

Publication number
JP2018524973A5
JP2018524973A5 JP2017562598A JP2017562598A JP2018524973A5 JP 2018524973 A5 JP2018524973 A5 JP 2018524973A5 JP 2017562598 A JP2017562598 A JP 2017562598A JP 2017562598 A JP2017562598 A JP 2017562598A JP 2018524973 A5 JP2018524973 A5 JP 2018524973A5
Authority
JP
Japan
Prior art keywords
hla
car
isolated
antibody
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017562598A
Other languages
English (en)
Japanese (ja)
Other versions
JP7010473B2 (ja
JP2018524973A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/035916 external-priority patent/WO2016197064A1/en
Publication of JP2018524973A publication Critical patent/JP2018524973A/ja
Publication of JP2018524973A5 publication Critical patent/JP2018524973A5/ja
Priority to JP2021182547A priority Critical patent/JP2022051570A/ja
Application granted granted Critical
Publication of JP7010473B2 publication Critical patent/JP7010473B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017562598A 2015-06-04 2016-06-03 Ｌｙｍ－１およびｌｙｍ－２標的化ｃａｒ細胞免疫療法 Expired - Fee Related JP7010473B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021182547A JP2022051570A (ja) 2015-06-04 2021-11-09 Ｌｙｍ－１およびｌｙｍ－２標的化ｃａｒ細胞免疫療法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562171004P 2015-06-04 2015-06-04
US62/171,004 2015-06-04
PCT/US2016/035916 WO2016197064A1 (en) 2015-06-04 2016-06-03 Lym-1 and lym-2 targeted car cell immunotherapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021182547A Division JP2022051570A (ja) 2015-06-04 2021-11-09 Ｌｙｍ－１およびｌｙｍ－２標的化ｃａｒ細胞免疫療法

Publications (3)

Publication Number Publication Date
JP2018524973A JP2018524973A (ja) 2018-09-06
JP2018524973A5 true JP2018524973A5 (OSRAM) 2019-06-13
JP7010473B2 JP7010473B2 (ja) 2022-02-10

Family

ID=57441999

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017562598A Expired - Fee Related JP7010473B2 (ja) 2015-06-04 2016-06-03 Ｌｙｍ－１およびｌｙｍ－２標的化ｃａｒ細胞免疫療法
JP2021182547A Pending JP2022051570A (ja) 2015-06-04 2021-11-09 Ｌｙｍ－１およびｌｙｍ－２標的化ｃａｒ細胞免疫療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021182547A Pending JP2022051570A (ja) 2015-06-04 2021-11-09 Ｌｙｍ－１およびｌｙｍ－２標的化ｃａｒ細胞免疫療法

Country Status (9)

Country Link
US (2) US10711064B2 (OSRAM)
EP (1) EP3302559B1 (OSRAM)
JP (2) JP7010473B2 (OSRAM)
CN (1) CN107847601A (OSRAM)
AU (1) AU2016270474A1 (OSRAM)
CA (1) CA2987992A1 (OSRAM)
HK (1) HK1253549A1 (OSRAM)
IL (1) IL256058B (OSRAM)
WO (1) WO2016197064A1 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4154907A1 (en) 2012-12-18 2023-03-29 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
KR101605421B1 (ko) 2014-03-05 2016-03-23 국립암센터 B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
JP2018504412A (ja) 2015-01-23 2018-02-15 アイカーン スクール オブ メディシン アット マウント サイナイ インフルエンザウイルスワクチン接種レジメン
US11787848B2 (en) * 2016-06-08 2023-10-17 Precigen, Inc. CD33 specific chimeric antigen receptors
WO2017218624A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
KR102664453B1 (ko) * 2017-02-21 2024-05-10 주식회사 유틸렉스 Hla-dr car-t 조성물 및 그를 제조하고 사용하는 방법
US11254733B2 (en) 2017-04-07 2022-02-22 Icahn School Of Medicine At Mount Sinai Anti-influenza B virus neuraminidase antibodies and uses thereof
WO2018204761A1 (en) * 2017-05-05 2018-11-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Rapid method for the culture of tumor infiltrating lymphocytes
CA3067223A1 (en) * 2017-06-13 2018-12-20 Beckman Coulter, Inc. Detection of leukocyte-derived microvesicles by fluo-sensitive flow cytometry
EP3810634A4 (en) 2018-06-21 2022-07-27 Icahn School of Medicine at Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
MX2021001672A (es) 2018-08-10 2021-07-15 Eutilex Co Ltd Receptor de antigeno quimerico que se une a hla-dr y linfocito t-car.
TWI850282B (zh) * 2018-11-27 2024-08-01 香港商弘年發展有限公司 用於治療癌症之質體建構體和使用方法
AU2020221324A1 (en) * 2019-02-15 2021-09-02 University Of Southern California Lym-1 and Lym-2 antibody compositions and improved CAR constructs
AU2020307673A1 (en) * 2019-06-27 2022-01-20 Eutilex Co., Ltd. Chimeric antigen receptor with 4-1BB costimulatory domain
US20230310606A1 (en) 2020-07-17 2023-10-05 Simurx, Inc. Chimeric myd88 receptors for redirecting immunosuppressive signaling and related compositions and methods
US20250108113A1 (en) * 2021-12-30 2025-04-03 Tr1X, Inc. Cd4+ t cells expressing il-10 and chimeric antigen receptors and uses thereof
CN117186242A (zh) * 2023-07-14 2023-12-08 上海市浦东医院（复旦大学附属浦东医院） 一种靶向vegfr2和pd-1的双靶点嵌合抗原受体及其应用
CN117106098A (zh) * 2023-07-14 2023-11-24 上海市浦东医院（复旦大学附属浦东医院） Vegfr2和pd-1双靶点三代嵌合抗原受体及其应用

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US707993A (en) 1901-05-16 1902-08-26 Clinton J Warren Machine for corking bottles.
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4724212A (en) 1985-05-24 1988-02-09 Northwestern University Murine hybridoma Lym-2 and diagnostic antibody produced thereby
US4724213A (en) 1985-05-24 1988-02-09 Northwestern University Murine hybridoma Lym-1 and diagnostic antibody produced thereby
EP1997891A1 (en) 1988-09-02 2008-12-03 Dyax Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US6352694B1 (en) 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
US6905680B2 (en) 1988-11-23 2005-06-14 Genetics Institute, Inc. Methods of treating HIV infected subjects
US6534055B1 (en) 1988-11-23 2003-03-18 Genetics Institute, Inc. Methods for selectively stimulating proliferation of T cells
US5858358A (en) 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
WO1991010737A1 (en) 1990-01-11 1991-07-25 Molecular Affinities Corporation Production of antibodies using gene libraries
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
DE69233750D1 (de) 1991-04-10 2009-01-02 Scripps Research Inst Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
SE9101433D0 (sv) 1991-05-13 1991-05-13 Marianne Hansson Recombinant dna sequence and its use
WO1992022324A1 (en) 1991-06-14 1992-12-23 Xoma Corporation Microbially-produced antibody fragments and their conjugates
ATE408012T1 (de) 1991-12-02 2008-09-15 Medical Res Council Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
WO1995015982A2 (en) 1993-12-08 1995-06-15 Genzyme Corporation Process for generating specific antibodies
DK1231268T3 (da) 1994-01-31 2005-11-21 Univ Boston Polyklonale antistofbiblioteker
US7175843B2 (en) 1994-06-03 2007-02-13 Genetics Institute, Llc Methods for selectively stimulating proliferation of T cells
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
GB9416721D0 (en) 1994-08-18 1994-10-12 Short Brothers Plc A bias yarn assembly forming device
US5712149A (en) 1995-02-03 1998-01-27 Cell Genesys, Inc. Chimeric receptor molecules for delivery of co-stimulatory signals
US6692964B1 (en) 1995-05-04 2004-02-17 The United States Of America As Represented By The Secretary Of The Navy Methods for transfecting T cells
US7067318B2 (en) 1995-06-07 2006-06-27 The Regents Of The University Of Michigan Methods for transfecting T cells
CA2229043C (en) 1995-08-18 2016-06-07 Morphosys Gesellschaft Fur Proteinoptimierung Mbh Protein/(poly)peptide libraries
JP2978435B2 (ja) 1996-01-24 1999-11-15 チッソ株式会社 アクリロキシプロピルシランの製造方法
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
EP1990409A3 (en) 1999-07-20 2011-05-18 MorphoSys AG Bacteriophage
DK1257632T3 (da) 2000-02-24 2008-01-28 Xcyte Therapies Inc Samtidig stimulering og opkoncentrering af celler
US6797514B2 (en) 2000-02-24 2004-09-28 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
US6867041B2 (en) 2000-02-24 2005-03-15 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
US7419829B2 (en) 2000-10-06 2008-09-02 Oxford Biomedica (Uk) Limited Vector system
NZ527937A (en) 2001-03-13 2005-03-24 Novartis Ag Stable cell lines to express high levels of lentiviral Gag/Pol proteins for generation of HIV- or BIV- based lentiviral vectors
CA2512647C (en) 2003-01-07 2013-10-08 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
AU2004219603A1 (en) 2003-03-11 2004-09-23 Genentech, Inc. Novel compositions and methods for the treatment of immune related disease
US20130266551A1 (en) 2003-11-05 2013-10-10 St. Jude Children's Research Hospital, Inc. Chimeric receptors with 4-1bb stimulatory signaling domain
CA2550155C (en) * 2003-12-15 2015-03-17 Dendreon Corporation Hla-dr-specific antibodies, compositions and methods
GB0408449D0 (en) 2004-04-15 2004-05-19 Banerjee Subhasis Diagnostic and therapeutic applications of soluble lhcge protein
US7527947B2 (en) 2004-06-14 2009-05-05 Novozymes A/S Signal peptide for producing a polypeptide
US20060063209A1 (en) 2004-08-20 2006-03-23 The Regents Of The University Of California Engineered antibody fragment that irreversibly binds an antigen
CN1331887C (zh) * 2004-08-20 2007-08-15 上海美恩生物技术有限公司 抗hla－dr10的淋巴瘤特异性嵌合单抗
EP3332808B1 (en) * 2005-03-03 2020-09-09 Immunomedics Inc. Humanized l243 antibodies
WO2007058725A2 (en) 2005-10-12 2007-05-24 The Regents Of The University Of California Engineered antibody fragment that irreversibly binds an antigen
PL3006459T3 (pl) 2008-08-26 2022-01-17 City Of Hope Sposób i kompozycje dla wzmocnionego działania efektorowego komórek t przeciw guzowi nowotworowemu
WO2010060186A1 (en) 2008-11-03 2010-06-03 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
PH12013501201A1 (en) 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
CN103041387B (zh) * 2011-10-11 2014-12-10 苏州工业园区晨健抗体组药物开发有限公司 恶性b细胞淋巴瘤抗体药物的新用途
EP2817330B1 (en) 2012-02-22 2020-07-08 The Trustees of the University of Pennsylvania Use of icos-based cars to enhance antitumor activity and car persistence
WO2013154760A1 (en) * 2012-04-11 2013-10-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chimeric antigen receptors targeting b-cell maturation antigen
US9534044B2 (en) 2013-02-28 2017-01-03 United Arab Emirates University Alpha-synuclein antibodies and uses thereof
KR101605421B1 (ko) * 2014-03-05 2016-03-23 국립암센터 B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
EP3273994B1 (en) 2015-03-27 2021-12-01 University of Southern California Car t-cell therapy directed to lhr for the treatment of solid tumors
US20190031759A1 (en) * 2015-04-30 2019-01-31 Technion Research & Development Foundation Limited Chimeric antigen receptors and methods of their use
KR102664453B1 (ko) * 2017-02-21 2024-05-10 주식회사 유틸렉스 Hla-dr car-t 조성물 및 그를 제조하고 사용하는 방법

Similar Documents

Publication Publication Date Title
JP2018524973A5 (OSRAM)
Chen et al. Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma
JP2018511319A5 (OSRAM)
Loo et al. Development of an Fc-enhanced anti–B7-H3 monoclonal antibody with potent antitumor activity
JP2017504324A5 (OSRAM)
Stevenson et al. The meaning and relevance of B-cell receptor structure and function in chronic lymphocytic leukemia
RU2016131207A (ru) Детерминанты ответа раковой опухоли на иммунотерапию
KR20190101989A (ko) 항 gpc3 항체
JP2013506428A5 (OSRAM)
Jovčevska et al. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers
EP3526257A2 (en) Modular tetravalent bispecific antibody platform
TW202212360A (zh) 抗ｃｌｄｎ１８．２抗體及其診斷用途
EP2820423A1 (en) Materials and methods for differential treatment of cancer
JP6944925B2 (ja) 組織浸潤ｎｋ細胞を検出する方法
US9676855B2 (en) B7-H6 therapeutically active monoclonal antibody against B7-H6 polypeptide
CN110072892A (zh) Mg7，高度糖基化cea特异性结合的单链抗体及其在检测和治疗上的应用
Moreno et al. High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC)
JP2021505663A5 (OSRAM)
Cyr et al. Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia
WO2019224385A2 (en) Combined bispecific antibody and immuno-oncology therapies
Dekanić et al. The prognostic significance of Nectin-2 and Nectin-4 expression in glial tumors
US11667711B2 (en) Anti-human LAG-3 antibodies and their use in immunohistochemistry (IHC)
US10796787B2 (en) Method for identifying antigen-specific T cell receptors in primate
Murphy et al. Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B)
Mao et al. A monoclonal antibody against human UL16-binding protein 3